CDKN2B-AS1 as a novel therapeutic target in cancer: Mechanism and clinical perspective.
Hjazi A, Ghaffar E, Asghar W, Alauldeen Khalaf H, Ikram Ullah M, Mireya Romero-Parra R, Hussien BM, Abdulally Abdulhussien Alazbjee A, Singh Bisht Y, Fakri Mustafa Y, Reza Hosseini-Fard S.
Hjazi A, et al. Among authors: fakri mustafa y.
Biochem Pharmacol. 2023 Jul;213:115627. doi: 10.1016/j.bcp.2023.115627. Epub 2023 May 29.
Biochem Pharmacol. 2023.
PMID: 37257723
Review.